crescent diagnostics ltd
crescent diagnostics ltd Company Information
Company Number
05131794
Next Accounts
125 days late
Directors
Shareholders
enterprise ireland
seroba bioventures ltd
View AllGroup Structure
View All
Industry
Other research and experimental development on natural sciences and engineering
Registered Address
101 new cavendish street, 1st floor south, london, W1W 6XH
Website
http://boneqt.comcrescent diagnostics ltd Estimated Valuation
Pomanda estimates the enterprise value of CRESCENT DIAGNOSTICS LTD at £220.2k based on a Turnover of £180.2k and 1.22x industry multiple (adjusted for size and gross margin).
crescent diagnostics ltd Estimated Valuation
Pomanda estimates the enterprise value of CRESCENT DIAGNOSTICS LTD at £0 based on an EBITDA of £-176.8k and a 5.65x industry multiple (adjusted for size and gross margin).
crescent diagnostics ltd Estimated Valuation
Pomanda estimates the enterprise value of CRESCENT DIAGNOSTICS LTD at £0 based on Net Assets of £-1.9m and 2.07x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Crescent Diagnostics Ltd Overview
Crescent Diagnostics Ltd is a live company located in london, W1W 6XH with a Companies House number of 05131794. It operates in the other research and experimental development on natural sciences and engineering sector, SIC Code 72190. Founded in May 2004, it's largest shareholder is enterprise ireland with a 94.5% stake. Crescent Diagnostics Ltd is a mature, micro sized company, Pomanda has estimated its turnover at £180.2k with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Crescent Diagnostics Ltd Health Check
Pomanda's financial health check has awarded Crescent Diagnostics Ltd a 1 rating. We use a traffic light system to show it exceeds the industry average on 0 measures and has 6 areas for improvement. Company Health Check FAQs
0 Strong
3 Regular
6 Weak
Size
annual sales of £180.2k, make it smaller than the average company (£4.1m)
- Crescent Diagnostics Ltd
£4.1m - Industry AVG
Growth
3 year (CAGR) sales growth of 5%, show it is growing at a similar rate (4.5%)
- Crescent Diagnostics Ltd
4.5% - Industry AVG
Production
with a gross margin of 47.1%, this company has a comparable cost of product (47.1%)
- Crescent Diagnostics Ltd
47.1% - Industry AVG
Profitability
an operating margin of -98.1% make it less profitable than the average company (4.8%)
- Crescent Diagnostics Ltd
4.8% - Industry AVG
Employees
with 2 employees, this is below the industry average (41)
2 - Crescent Diagnostics Ltd
41 - Industry AVG
Pay Structure
on an average salary of £63.9k, the company has an equivalent pay structure (£63.9k)
- Crescent Diagnostics Ltd
£63.9k - Industry AVG
Efficiency
resulting in sales per employee of £90.1k, this is less efficient (£121.7k)
- Crescent Diagnostics Ltd
£121.7k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Crescent Diagnostics Ltd
- - Industry AVG
Creditor Days
its suppliers are paid after 28 days, this is quicker than average (44 days)
- Crescent Diagnostics Ltd
44 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Crescent Diagnostics Ltd
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Crescent Diagnostics Ltd
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 183%, this is a higher level of debt than the average (46.2%)
183% - Crescent Diagnostics Ltd
46.2% - Industry AVG
CRESCENT DIAGNOSTICS LTD financials
Crescent Diagnostics Ltd's latest turnover from December 2022 is estimated at £180.2 thousand and the company has net assets of -£1.9 million. According to their latest financial statements, Crescent Diagnostics Ltd has 2 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Oct 2011 | Oct 2010 | Oct 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | ||||||||||||||
| Other Income Or Grants | ||||||||||||||
| Cost Of Sales | ||||||||||||||
| Gross Profit | ||||||||||||||
| Admin Expenses | ||||||||||||||
| Operating Profit | ||||||||||||||
| Interest Payable | ||||||||||||||
| Interest Receivable | ||||||||||||||
| Pre-Tax Profit | ||||||||||||||
| Tax | ||||||||||||||
| Profit After Tax | ||||||||||||||
| Dividends Paid | ||||||||||||||
| Retained Profit | ||||||||||||||
| Employee Costs | ||||||||||||||
| Number Of Employees | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Oct 2011 | Oct 2010 | Oct 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 484 | 2,614 | 5,250 | 767 | 1,548 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 731,107 | 731,107 | 731,107 | 731,107 | 731,107 | 731,107 | 731,107 | 731,107 | 385,071 | 385,071 | 385,071 | 385,071 | 385,071 | 385,071 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 1,519,652 | 1,519,652 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 731,107 | 731,107 | 731,107 | 2,250,759 | 2,250,759 | 731,107 | 731,107 | 731,107 | 385,071 | 385,555 | 387,685 | 390,321 | 385,838 | 386,619 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,526,104 | 1,439,882 | 1,294,363 | 540,225 | 154,742 | 71,032 |
| Group Debtors | 1,519,652 | 1,519,652 | 1,519,652 | 0 | 0 | 1,519,652 | 1,519,652 | 1,519,652 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 0 | 332 | 334 | 335 | 345 | 334 | 2,214 | 2,183 | 2,465 | 1,036 | 12,296 | 736,590 | 60,643 | 30,281 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 1,519,652 | 1,519,984 | 1,519,986 | 335 | 345 | 1,519,986 | 1,521,866 | 1,521,835 | 1,528,569 | 1,440,918 | 1,306,659 | 1,276,815 | 215,385 | 101,313 |
| total assets | 2,250,759 | 2,251,091 | 2,251,093 | 2,251,094 | 2,251,104 | 2,251,093 | 2,252,973 | 2,252,942 | 1,913,640 | 1,826,473 | 1,694,344 | 1,667,136 | 601,223 | 487,932 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 7,418 | 3,938 | 3,938 | 3,939 | 2,954 | 1,914 | 928 | 9,414 | 2,709,886 | 2,510,517 | 2,046,158 | 1,572,253 | 272,403 | 13,430 |
| Group/Directors Accounts | 0 | 507,193 | 505,318 | 502,477 | 502,477 | 501,052 | 502,932 | 491,573 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 4,427 | 4,427 | 4,426 | 5,841 | 4,424 | 2,937,112 | 2,811,969 | 2,688,672 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current liabilities | 11,845 | 515,558 | 513,682 | 512,257 | 509,855 | 3,440,078 | 3,315,829 | 3,189,659 | 2,709,886 | 2,510,517 | 2,046,158 | 1,572,253 | 272,403 | 13,430 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 4,107,852 | 3,427,644 | 3,303,895 | 3,180,146 | 3,056,397 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 4,107,852 | 3,427,644 | 3,303,895 | 3,180,146 | 3,056,397 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 4,119,697 | 3,943,202 | 3,817,577 | 3,692,403 | 3,566,252 | 3,440,078 | 3,315,829 | 3,189,659 | 2,709,886 | 2,510,517 | 2,046,158 | 1,572,253 | 272,403 | 13,430 |
| net assets | -1,868,938 | -1,692,111 | -1,566,484 | -1,441,309 | -1,315,148 | -1,188,985 | -1,062,856 | -936,717 | -796,246 | -684,044 | -351,814 | 94,883 | 328,820 | 474,502 |
| total shareholders funds | -1,868,938 | -1,692,111 | -1,566,484 | -1,441,309 | -1,315,148 | -1,188,985 | -1,062,856 | -936,717 | -796,246 | -684,044 | -351,814 | 94,883 | 328,820 | 474,502 |
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Oct 2011 | Oct 2010 | Oct 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Operating Profit | ||||||||||||||
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2,130 | 3,116 | 477 | 1,720 | 1,489 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | ||||||||||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -6,452 | 86,222 | 145,519 | 754,138 | 385,483 | 83,710 | 71,032 |
| Creditors | 3,480 | 0 | -1 | 985 | 1,040 | 986 | -8,486 | -2,700,472 | 199,369 | 464,359 | 473,905 | 1,299,850 | 258,973 | 13,430 |
| Accruals and Deferred Income | 0 | 1 | -1,415 | 1,417 | -2,932,688 | 125,143 | 123,297 | 2,688,672 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | ||||||||||||||
| Investing Activities | ||||||||||||||
| capital expenditure | ||||||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 346,036 | 0 | 0 | 0 | 0 | 0 | 385,071 |
| cash flow from investments | ||||||||||||||
| Financing Activities | ||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | -507,193 | 1,875 | 2,841 | 0 | 1,425 | -1,880 | 11,359 | 491,573 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 680,208 | 123,749 | 123,749 | 123,749 | 3,056,397 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||||||
| interest | ||||||||||||||
| cash flow from financing | ||||||||||||||
| cash and cash equivalents | ||||||||||||||
| cash | -332 | -2 | -1 | -10 | 11 | -1,880 | 31 | -282 | 1,429 | -11,260 | -724,294 | 675,947 | 30,362 | 30,281 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | -332 | -2 | -1 | -10 | 11 | -1,880 | 31 | -282 | 1,429 | -11,260 | -724,294 | 675,947 | 30,362 | 30,281 |
crescent diagnostics ltd Credit Report and Business Information
Crescent Diagnostics Ltd Competitor Analysis
Perform a competitor analysis for crescent diagnostics ltd by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other micro companies, companies in W1W area or any other competitors across 12 key performance metrics.
crescent diagnostics ltd Ownership
CRESCENT DIAGNOSTICS LTD group structure
Crescent Diagnostics Ltd has no subsidiary companies.
Ultimate parent company
CRESCENT DIAGNOSTICS LTD
05131794
crescent diagnostics ltd directors
Crescent Diagnostics Ltd currently has 1 director, Mr Barry Clare serving since Jun 2013.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Barry Clare | 71 years | Jun 2013 | - | Director |
P&L
December 2022turnover
180.2k
+10%
operating profit
-176.8k
0%
gross margin
47.1%
+2.41%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2022net assets
-1.9m
+0.1%
total assets
2.3m
0%
cash
0
-1%
net assets
Total assets minus all liabilities
crescent diagnostics ltd company details
company number
05131794
Type
Private limited with Share Capital
industry
72190 - Other research and experimental development on natural sciences and engineering
incorporation date
May 2004
age
21
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
December 2022
previous names
N/A
accountant
-
auditor
-
address
101 new cavendish street, 1st floor south, london, W1W 6XH
Bank
-
Legal Advisor
-
crescent diagnostics ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 3 charges/mortgages relating to crescent diagnostics ltd. Currently there are 3 open charges and 0 have been satisfied in the past.
crescent diagnostics ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for CRESCENT DIAGNOSTICS LTD. This can take several minutes, an email will notify you when this has completed.
crescent diagnostics ltd Companies House Filings - See Documents
| date | description | view/download |
|---|
